Brain scans aim to uncover hidden risk in Parkinson's patients

NCT ID NCT07213219

Recruiting now Knowledge-focused Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study will use PET-MRI brain scans to compare the reward system in 44 Parkinson's patients, some of whom have a sleep disorder called RBD. The goal is to understand why some patients develop impulse control problems, like gambling or compulsive behaviors, as a side effect of their medication. By identifying brain differences, doctors hope to personalize treatment and reduce these risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Disruptive, Impulse Control, and Conduct Disorders Parkinson disease REM sleep behavior disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE (PD)

Contacts and locations

Locations

CH Le Puy en Velay
RECRUITING

Le Puy-en-Velay, France
CHRU Lyon
RECRUITING

Lyon, France
CHU Clermont-Ferrand, Clermont-Ferrand,
RECRUITING

Clermont-Ferrand, 63000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.